Syra Health Corp. (SYRA) Fair Value 2026

SYRA · Medical Care Facilities ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

5.9 /10

32 fundamental signals · 2 models active

Value Trap Risk

LOW (33/100)

Quick Summary — As of 2026-08-27, Syra Health Corp. (SYRA) trades at $0.80, versus a $0.55 median fair value across its 2 active models — 31.5% below the current price. QOC: 5.9/10. Value Trap Risk: 33/100 (LOW). 2/13 models active.

Key Facts

Ticker
SYRA
Price
$0.80
Quality Score
5.9/10
Value Trap Risk
33/100
Models Active
2/13
Last Updated
Strength: Regime Cross-Sectional suggests +33.8% upside with 16% confidence
Risk: Limited model coverage (2/13) may reduce confidence

Is Syra Health Corp. (SYRA) Undervalued or Overvalued in 2026?

According to CirclFi’s 2-model valuation engine, Syra Health Corp. (SYRA) appears overvalued as of : the median of 2 independent fair value estimates is $0.55, 31.5% below the current price of $0.80. Estimates range from $0.03 to $1.07. SYRA scores 5.9/10 on fundamental quality and 33/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -23.7% versus its own 13-model consensus, across 3,801 rated companies as of 2026-08-27. SYRA’s -31.5% gap is wider than that market norm, and the Medical Care Facilities sector median is -28.6%. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy Syra Health Corp. Stock in 2026? →

What Fair Value Does Each Model Give SYRA?

2 Intrinsic Value Models vs. Current Price ($0.80)

Core Models (Unlocked)
Model Fair Value Upside
Intrinsic · Medium Conviction
 $0.03 -96.9%
Relative · Low Conviction
 $1.07 +33.8%

All Models Active

All 2 models are displayed above.

What Is Syra Health Corp. (SYRA) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Syra Health Corp.'s intrinsic value is estimated at $0.55, presenting a divided outlook at the current price of $0.80. With a median implied return of -31.5% across a split 1–1 (bull–bear) consensus, the model spread of +130.7% underscores analytical uncertainty. Notably, Regime Cross sees the most upside at +33.8% (fair value: $1.07), while ML-RIV is the most conservative at -96.9% ($0.03). The spread between these extremes — +130.7% — reveals how different analytical frameworks can reach starkly different conclusions.

What Do the Models Say About SYRA?

2 of 13 models are currently active for SYRA. Of these, 1 model suggests upside while 1 model suggests overvaluation. Taken together, their median fair value for SYRA is $0.55 — the figure CirclFi publishes as this stock's fair value. See which stocks rank higher →

How Does SYRA Rank in Medical Care Facilities?

Among 60 Medical Care Facilities stocks, SYRA ranks #38 by Quality of Company score. CirclFi's QOC score of 5.9/10 evaluates 32 fundamental signals. A score of 5.9 reflects mixed fundamentals.

See all Most Undervalued Medical Care Facilities Stocks →

Syra Health Corp. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is SYRA a Value Trap?

CirclFi's Value Trap algorithm assigns SYRA a score of 33/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

2 of 13 models are active for Syra Health Corp.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, which evaluates 32 signals including margin stability, revenue growth trajectory, leverage, and free cash flow generation, Syra Health Corp. is rated at 5.9/10. This solid-tier score maintains reasonable quality metrics with some areas for improvement.

The gap between the most bullish and bearish model spans +130.7% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every SYRA valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across SYRA's 2 active models, average confidence is 32%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Syra Health Corp. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medical Care Facilities Stocks Should You Also Analyze?

11 related Medical Care Facilities stocks with 13-model coverage

CCMConcord Medical Services Holdings LimitedQOC 6.1AGLagilon health, inc.QOC 5.9MCTACharming Medical LimitedQOC 6.1GBCSSelectis Health, Inc.QOC 5.9AIRSAirSculpt Technologies, Inc.QOC 6.1AMSAmerican Shared Hospital ServicesQOC 5.9CMPSCOMPASS Pathways plcQOC 4.5THCTenet Healthcare CorporationQOC 8.3JYNTThe Joint Corp.QOC 7.2ADUSAddus HomeCare CorporationQOC 8.9NHCNational HealthCare CorporationQOC 8.7

Read investment analysis: CCM · AGL · MCTA · GBCS · AIRS · AMS · CMPS · THC · JYNT · ADUS · NHC

Which Other Stocks Have a Similar Quality Score to SYRA?

7 companies across all industries closest to SYRA’s Quality of Company score of 5.9/10.

AEVAAeva Technologies, Inc.QOC 5.9PBSVPharma-Bio Serv, Inc.QOC 5.9ARCCAres Capital CorporationQOC 5.9SKYHSky Harbour Group CorporationQOC 5.9BETABETA Technologies, Inc.QOC 5.9ABEOAbeona Therapeutics Inc.QOC 5.9NVDANVIDIA CorporationQOC 10.0

Read investment analysis: AEVA · PBSV · ARCC · SKYH · BETA · ABEO · NVDA

Where Does SYRA Sit in CirclFi's Medical Care Facilities Rankings?

SYRA is ranked against every other Medical Care Facilities stock CirclFi covers in each of these screens.

See all Medical Care Facilities stocks ranked →

What Else Do Investors Ask About Syra Health Corp.’s Valuation?

What is Syra Health Corp.'s intrinsic value in 2026?

CirclFi puts Syra Health Corp. (SYRA)'s intrinsic value at $0.55 — the median of 2 independent model estimates as of 2026-08-27, ranging from $0.03 to $1.07. The Quality of Company score is 5.9/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is SYRA overvalued or undervalued right now?

At $0.80, 1 of 2 active models suggest SYRA may be undervalued, while 1 indicate potential overvaluation. The median of all 2 fair value estimates is $0.55, 31.5% below the current price of $0.80 — a consensus view that SYRA is overvalued. The assessment depends on which methodology best fits Syra Health Corp.'s business model in Medical Care Facilities.

What does a Quality of Company score of 5.9 mean for SYRA?

Syra Health Corp.'s QOC of 5.9/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores between 5-7 reflect moderate fundamentals with areas for improvement.

How many valuation models does CirclFi run on SYRA?

CirclFi analyzes SYRA with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 2 of 13 are active for this stock. Read the full methodology →

Is SYRA a value trap in 2026?

Syra Health Corp.'s Value Trap score is 33/100 (LOW). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

Cite this analysis — “According to CirclFi’s 2-model valuation engine, Syra Health Corp. (SYRA) has a median fair value of $0.55 — 31.5% below the current price of $0.80 — as of 2026-08-27.” Source: circlfi.com/stock/SYRA/ · Methodology
Primary sources for this SYRA valuation
  • Financial statements: Syra Health Corp. 10-K and 10-Q filings on SEC EDGAR (CIK 0001922335) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for SYRA as of ; valuations recomputed .